Pb-based halide perovskites have recently showed great potential in various applications such as solar cells, optoelectronics and photocatalysis. Despite their high performance, the Pb2+ toxicity along with poor stability hinder...
CO2 photocatalytic conversion into value-added
fuels
through solar energy is a promising way of storing renewable energy
while simultaneously reducing the concentration of CO2 in
the atmosphere. Lead-based halide perovskites have recently shown
great potential in various applications such as solar cells, optoelectronics,
and photocatalysis. Even though they show high performance, the high
toxicity of Pb2+ along with poor stability under ambient
conditions restrains the application of these materials in photocatalysis.
In this respect, we developed an in situ assembly strategy to fabricate
the lead-free double perovskite Cs2AgBiBr6 on
a 2D bismuthene nanosheet prepared by a ligand-assisted reprecipitation
method for a liquid-phase CO2 photocatalytic reduction
reaction. The composite improved the production and selectivity of
the eight-electron CH4 pathway compared with the two-electron
CO pathway, storing more of the light energy harvested by the photocatalyst.
The Cs2AgBiBr6/bismuthene composite shows a
photocatalytic activity of 1.49(±0.16) μmol g–1 h–1 CH4, 0.67(±0.14) μmol
g–1 h–1 CO, and 0.75(±0.20)
μmol g–1 h–1 H2, with a CH4 selectivity of 81(±1)% on an electron
basis with 1 sun. The improved performance is attributed to the enhanced
charge separation and suppressed electron–hole recombination
due to good interfacial contact between the perovskite and bismuthene
promoted by the synthesis method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.